Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2024-12-11 Major Shareholding Noti…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with "RNS Number : 6025P" and contains the standard header/footer information associated with RNS (Regulatory News Service) announcements from the London Stock Exchange. The content is a "TR-1: Standard form for notification of major holdings," which details changes in voting rights held by a shareholder (Citigroup Global Markets Limited). This type of filing, which reports changes in significant share ownership crossing specific thresholds, directly corresponds to the Major Shareholding Notification category (MRQ). Although RNS is the distribution mechanism, the specific content dictates the classification.
2024-12-11 English
PRTC's Seaport Presents Ph1 SPT-300 Data at ACNP
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number header and contains a date (11 December 2024) and company information (PureTech Health PLC). The content describes an announcement regarding a subsidiary's (Seaport Therapeutics) presentation of clinical data (Phase 1 study of SPT-300) at a scientific meeting (ACNP Annual Meeting). This type of announcement, which disseminates material, non-financial news via a regulatory news service (RNS), fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (like 10-K, ER, IR) or a specific corporate action (like DIV, CAP, DIRS). The document structure strongly suggests a standard regulatory news service release.
2024-12-11 English
PRTC Presents LYT-200 Phase 1b Data in AML at ASH
Regulatory Filings Classification · 98% confidence The document is identified by the header 'RNS Number' and contains a press release format announcing clinical data presentation at a medical conference (ASH Annual Meeting). It details scientific findings, safety profiles, and future development plans for a drug (LYT-200). This type of announcement, which is a formal update disseminated via the Regulatory News Service (RNS) but is not a statutory financial report (like 10-K or IR) or a specific corporate action notice (like DIV or SHA), falls best under the general 'Regulatory Filings' category, which serves as a fallback for miscellaneous regulatory announcements distributed through RNS. Since it is a full announcement and not just a notice that a report is attached, it is not RPA.
2024-12-09 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 9095N' and contains the standard formatting for a regulatory notification disseminated via RNS (the news service of the London Stock Exchange). The content is a 'TR-1: Standard form for notification of major holdings,' which reports changes in voting rights/share ownership thresholds. This type of filing specifically relates to changes in significant shareholdings, matching the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2024-11-27 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 8988N' and contains the standard boilerplate text referencing 'RNS, the news service of the London Stock Exchange.' The content itself is a 'TR-1: Standard form for notification of major holdings,' which details changes in voting rights by a shareholder (Citigroup Global Markets Limited). This type of mandatory disclosure regarding significant changes in share ownership thresholds falls directly under the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2024-11-27 English
PRTC's Seaport Adds Microsoft and J&J Exec to BOD
Board/Management Information Classification · 98% confidence The document is an official announcement disseminated via RNS (RNS Number : 8957M) on November 20, 2024. The core content announces that PureTech Health's Founded Entity, Seaport Therapeutics, has added Sandi Peterson to its Board of Directors. This constitutes an announcement regarding a change in the company's board of directors or senior management structure. This aligns directly with the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific content is not a general regulatory filing but a specific corporate governance update.
2024-11-20 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.